Ely Lilly Claims Experimental Drug Protects Covid-19 Patients – The New York Times

A so-called monoclonal antibody lowered blood levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here